Benefits
Antioxidant Properties
Catechins such as EGCG neutralize free radicals in laboratory tests. In pooled human trials, green tea supplements raised total antioxidant capacity and improved markers such as malondialdehyde, superoxide dismutase and glutathione peroxidase. These are blood markers; a large review found the evidence too inconsistent to recommend green tea for cancer prevention.
Weight Management Support
A meta-analysis of 11 studies found catechins, or EGCG mixed with caffeine, gave about 1.3 kg more weight loss, or better weight maintenance, than control. The effect looked smaller in people who habitually take in over 300 mg of caffeine a day, although that difference was not statistically significant. It is a small add-on to diet and activity, not a substitute.
Cardiovascular Health
In a meta-analysis of 14 randomized trials, green tea lowered total cholesterol by about 7 mg/dL and LDL cholesterol by about 2 mg/dL, with no HDL change. A pooled analysis of 55 trials found similar cholesterol drops, a diastolic blood pressure drop under 1 mmHg and no significant change in systolic pressure. These are small shifts in risk markers, not proof of fewer heart attacks or strokes.
Cognitive Function
Human evidence on thinking skills is thin. A review of matcha, the powdered whole-leaf form of green tea, found only a few randomized trials, with less stress and slightly better attention and memory in some but contradictory results overall. Brain-protective effects of EGCG come from laboratory and animal studies and have not been shown in people.
Inflammation Markers: IL-1 Beta Lowered, CRP Unchanged
A pooled analysis of 38 randomized trials found green tea lowered one inflammatory marker, IL-1 beta, slightly, but had no significant effect on CRP, IL-6 or TNF-alpha. A separate analysis also found no CRP change, and a 45-day trial saw no change in inflammation markers. This is weak evidence for any anti-inflammatory effect.
Mechanism of action
Antioxidant Activity
In laboratory studies, catechins, especially EGCG, scavenge free radicals. In pooled human trials, green tea raised total antioxidant capacity and improved the antioxidant enzymes superoxide dismutase and glutathione peroxidase; these are blood markers rather than health outcomes.
Energy Use and Fat Burning
In a pooled analysis of six respiration-chamber studies, catechin and caffeine mixtures raised 24-hour energy expenditure by about 4.7% and fat burning by about 16% compared with placebo; caffeine alone raised energy expenditure by a similar amount but did not significantly raise fat burning. In weight-loss trials the net effect was small, about 1.3 kg more than control.
Cardiovascular Benefits
Catechins are proposed to reduce cholesterol absorption in the gut and to support blood vessel function. The changes measured in human trials are small: total cholesterol fell about 7 mg/dL and diastolic blood pressure fell by less than 1 mmHg.
Brain-Active Compounds
Green tea contains caffeine, which increases alertness, and L-theanine, an amino acid studied for attention on its own and together with caffeine. EGCG has been reported to cross the blood-brain barrier, and its brain-protective effects come from laboratory and animal studies, not human trials.
Anti-Inflammatory and Immune Modulation
In laboratory studies, catechins inhibit pro-inflammatory pathways such as NF-kB and modulate immune cell activity. In human trials, however, most blood inflammation markers did not change.
Clinical trials
Randomized, double-blind, placebo-controlled, parallel-group trial in Japan. Daily green tea providing 146 mg EGCG combined with 178 mg alpha-glucosyl hesperidin, or placebo, for 12 weeks. Designed and funded by Toyota Motor Corporation, which has a patent pending with Kyushu University. (Yoshitomi et al. 2021, Sci Rep)
60 healthy Japanese men and women aged 30 to 75.
At 12 weeks the combination prevented weight gain and lowered BMI compared with placebo, and safety tests showed no problems. Body fat and visceral fat fell mainly in people under 50. Because two ingredients were combined, the effect cannot be credited to green tea alone.
Systematic review and meta-analysis of randomized trials measuring total antioxidant capacity (TAC) and malondialdehyde (MDA), a marker of oxidative damage to fats, using a random-effects model. (Rasaei et al. 2021, Antioxidants (Basel))
16 randomized trials (17 arms) with 760 adults.
Green tea raised total antioxidant capacity by 0.20 mmol/L (95% CI 0.09 to 0.30), with very high heterogeneity between studies. Overall MDA did not change, although higher doses were linked to larger MDA drops in a meta-regression. These are blood markers, not health outcomes.
Systematic review and meta-analysis of randomized trials of green tea supplementation on blood lipids, blood pressure, blood sugar markers and CRP, using a random-effects model. (Zamani et al. 2022, Front Nutr)
55 randomized trials with 63 effect sizes.
Green tea lowered total cholesterol by 7.62 mg/dL, LDL cholesterol by 5.80 mg/dL and diastolic blood pressure by 0.87 mmHg, slightly lowered fasting blood sugar and HbA1c, and raised HDL cholesterol by 1.85 mg/dL. Systolic blood pressure and CRP did not change significantly. The changes are small.
Randomized, double-blind, placebo-controlled trial in China. 400 mg/day decaffeinated green tea polyphenols or placebo for 12 weeks; the main aim was safety. (Yao et al. 2024, Asia Pac J Clin Nutr)
62 girls aged 6 to 10 with obesity (31 per group).
Liver and kidney markers, blood minerals and blood counts did not differ between groups, and no adverse effects were reported. Uric acid fell more with the polyphenols but stayed in the normal range. A trial this small cannot detect rare liver injury, so it does not show that extracts are safe for children in general.
Randomized clinical trial of green tea tablets or placebo for 45 days, measuring weight, BMI, waist, body fat and the inflammation markers IL-6, hs-CRP and TNF-alpha. (Mombaini et al. 2017, Phytother Res)
45 women with polycystic ovary syndrome (PCOS).
Weight, BMI, waist and body fat fell within the green tea group, but the differences between green tea and placebo were not significant. Inflammation markers did not change. Both outcomes were null versus placebo.
Systematic review and meta-analysis of clinical trials of green tea supplementation in adults with nonalcoholic fatty liver disease (NAFLD). (Mansour-Ghanaei et al. 2018, Phytother Res)
Four clinical trials in adults with NAFLD.
Green tea lowered the liver enzymes ALT (by 12.81 U/L) and AST (by 10.91 U/L), and also BMI, triglycerides, total cholesterol and LDL cholesterol, with no significant change in HDL cholesterol or insulin resistance. Only four trials were pooled.
GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. (Dehzad et al. 2025, J Nutr Sci)
38 randomized trials in adults.
Green tea improved IL-1 beta, MDA, total antioxidant capacity, superoxide dismutase and glutathione peroxidase, but had no significant effect on CRP, IL-6 or TNF-alpha. The authors concluded that green tea can improve oxidative status but showed no significant effect on inflammatory markers except IL-1 beta.